-transparent.png){kind=logo}
The efficacy of gemfibrozil as a hypolipidaemic agent was compared with that of clofibrate in a cohort of 80 subjects, half being treated with gemfibrozil and half with clofibrate. The majority of the subjects were either of the type IIa or IIb. Both drugs proved to be effective, though there were 13 non-responders in the clofibrate group, compared with 8 in the gemfibrozil group. The mean reduction in serum cholesterol induced by clofibrate was 23% and by gemfibrozil 19%. The corresponding falls in serum triglycerides were 36% and 43%. There were no serious side effects in either group. Analysed in this way, the relative efficiencies of gemfibrozil and clofibrate seem to be indistinguishable. Further studies are being directed towards evaluation of the individual responses to both treatments.
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
January 1976,
Proceedings of the Royal Society of Medicine,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
January 1976,
Proceedings of the Royal Society of Medicine,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
January 1976,
Proceedings of the Royal Society of Medicine,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
January 1972,
Atherosclerosis,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
August 1999,
Journal of hepatology,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
November 1980,
The New Zealand medical journal,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
November 1990,
The Journal of the Association of Physicians of India,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
May 1969,
Diabetes,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
September 1978,
JPMA. The Journal of the Pakistan Medical Association,
J Tuomilehto, and
J Salonen, and
P Kuuisto, and
J Virtamo, and
V Manninen, and
M Mälkönen
October 1988,
Atherosclerosis,
